Thermo Fisher Scientific Inc. (TMO)

NASDAQ

$575.78

+$3.50 (0.61%)

Today

No price data available for this timeframe.

Key Statistics

Day Range

$565.67$576.00

Open $572.50

52 Week Range

$385.46$610.97

Previous Close $572.28

Market Cap218.22B

Volume1.18M

Avg Volume2.04M

P/E (TTM)33.13

EPS (TTM)$17.38

Dividend / Yield$1.29 (0.22%)

Dividend Streak8 years

Analyst Ratings & Targets

Price Target

Consensus Target

$630.70

Based on 17 analysts (last year)

High Target

$750.00

Low Target

$561.00

Current

$575.78

Target

$630.70

$561.00$750.00

Potential upside of 9.54%

Based on consensus price target

Price Target Timeframes

Last Month

$703.33

3 analysts

Last Quarter

$628.27

11 analysts

Last Year

$613.24

17 analysts

All Time

$629.28

57 analysts

Analyst Consensus

Current Consensus

Buy

Based on 42 analyst ratings

Strong BuyBuyHoldSellStrong Sell

Stock Valuation Score

Rating:

B+

(Score: 3)

DCFDiscounted Cash Flow - Evaluates fair stock value based on expected future cash flows4/5

ROEReturn On Equity - Measures profitability relative to shareholders' equity4/5

ROAReturn On Assets - Shows how efficiently a company uses its assets to generate profits5/5

D/EDebt to Equity - Ratio comparing company's debt to its shareholders' equity

Recent Price Target Updates

Date	Analyst	Firm	Target	Price	Upside
Dec 15, 2025	Unknown	Wells Fargo	$675.00	$571.99	+18.01%
Dec 9, 2025	Evie Koslosky	Goldman Sachs	$685.00	$568.21	+20.55%
Dec 7, 2025	Paul Knight	KeyBanc	$750.00	$572.77	+30.94%
Oct 29, 2025	Unknown	Argus Research	$610.00	$570.82

Recent Analyst Actions


Dec 15, 2025	Maintained	Wells Fargo	Overweight	Overweight
Dec 11, 2025	Upgrade	Citigroup	Neutral	Buy
Dec 8, 2025	Upgrade	Keybanc	Sector Weight	Overweight
Dec 2, 2025	Maintained	Morgan Stanley	Overweight	Overweight
Dec 1, 2025	Upgrade	HSBC	Hold	Buy

Showing 1 to 5 of 526 entries

Analyst Ratings & Targets

Price Target

Consensus Target

$630.70

Based on 17 analysts (last year)

High Target

$750.00

Low Target

$561.00

Current

$575.78

Target

$630.70

$561.00$750.00

Potential upside of 9.54%

Based on consensus price target

Price Target Timeframes

Last Month

$703.33

3 analysts

Last Quarter

$628.27

11 analysts

Last Year

$613.24

17 analysts

All Time

$629.28

57 analysts

Analyst Consensus

Current Consensus

Buy

Based on 42 analyst ratings

Strong BuyBuyHoldSellStrong Sell

Stock Valuation Score

Rating:

B+

(Score: 3)

DCFDiscounted Cash Flow - Evaluates fair stock value based on expected future cash flows4/5

ROEReturn On Equity - Measures profitability relative to shareholders' equity4/5

ROAReturn On Assets - Shows how efficiently a company uses its assets to generate profits5/5

D/EDebt to Equity - Ratio comparing company's debt to its shareholders' equity

Recent Price Target Updates

Date	Analyst	Firm	Target	Price	Upside
Dec 15, 2025	Unknown	Wells Fargo	$675.00	$571.99	+18.01%
Dec 9, 2025	Evie Koslosky	Goldman Sachs	$685.00	$568.21	+20.55%
Dec 7, 2025	Paul Knight	KeyBanc	$750.00	$572.77	+30.94%
Oct 29, 2025	Unknown	Argus Research	$610.00	$570.82

Recent Analyst Actions


Dec 15, 2025	Maintained	Wells Fargo	Overweight	Overweight
Dec 11, 2025	Upgrade	Citigroup	Neutral	Buy
Dec 8, 2025	Upgrade	Keybanc	Sector Weight	Overweight
Dec 2, 2025	Maintained	Morgan Stanley	Overweight	Overweight
Dec 1, 2025	Upgrade	HSBC	Hold	Buy

Showing 1 to 5 of 526 entries